{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:00:27Z","timestamp":1762002027812,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE-1745038"],"award-info":[{"award-number":["DGE-1745038"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013927","name":"National MPS Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013927","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["F31 HL165903-01A1"],"award-info":[{"award-number":["F31 HL165903-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016853","name":"Lysosomal Disease Network","doi-asserted-by":"publisher","award":["U54-NS065768"],"award-info":[{"award-number":["U54-NS065768"]}],"id":[{"id":"10.13039\/100016853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ymgmr.2023.101036","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T02:00:01Z","timestamp":1702519201000},"page":"101036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type I"],"prefix":"10.1016","volume":"38","author":[{"given":"Sarah C.","family":"Hurt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moin U.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven Q.","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-hsin","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quang","family":"Bui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia I.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2023.101036_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","volume":"vol. 8","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgmr.2023.101036_bb0010","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/jimd.12414","article-title":"Mucopolysaccharidoses type I gene therapy","volume":"44","author":"Hurt","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-9149(76)90468-9","article-title":"The heart in the Hurler syndrome: gross, histologic and ultrastructural observations in five necropsy cases","volume":"38","author":"Renteria","year":"1976","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0020","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0002-9149(81)90550-6","article-title":"Coronary artery disease in the hurler syndrome. Qualitative and quantitative analysis of the extent of coronary narrowing at necropsy in six children","volume":"47","author":"Brosius","year":"1981","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0025","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management","volume":"34","author":"Braunlin","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0030","doi-asserted-by":"crossref","first-page":"e1343","DOI":"10.1542\/peds.2009-2047","article-title":"Fatal coronary artery disease in an infant with severe Mucopolysaccharidosis Type I","volume":"127","author":"van den Broek","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgmr.2023.101036_bb0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","article-title":"Joint and bone disease in Mucopolysaccharidoses VI and VII: identification of new therapeutic targets and BioMarkers using animal models","volume":"57","author":"Simonaro","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","article-title":"Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases","volume":"172","author":"Simonaro","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1073\/pnas.0912937107","article-title":"Involvement of the toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses","volume":"107","author":"Simonaro","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054459","article-title":"Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses","volume":"8","author":"Schuchman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgmr.2023.101036_bb0055","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/labinvest.2011.7","article-title":"Arterial pathology in canine mucopolysaccharidosis-I and response to therapy","volume":"91","author":"Lyons","year":"2011","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0060","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.ymgme.2013.12.272","article-title":"Innate immune system activation in MPS I canine vascular disease","volume":"111","author":"Vera","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0065","first-page":"S110","article-title":"Aortic gene expression from the canine model of MPS I identifies upregulation of genes related to antigen presentation and inflammatory cytokines, and downregulation of cellular adhesion and cytoskeletal genes","volume":"111","author":"Wang","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0070","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ymgme.2009.12.003","article-title":"Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression","volume":"99","author":"Metcalf","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2005.05.003","article-title":"Cardiac manifestations in the mouse model of mucopolysaccharidosis I","volume":"86","author":"Jordan","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0080","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymgme.2008.03.018","article-title":"Upregulation of elastase proteins results in aortic dilatation in mucopolysaccharidosis I mice","volume":"94","author":"Ma","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0085","first-page":"55","article-title":"The transforming growth factor-beta signaling pathway involvement in cardiovascular lesions in mucopolysaccharidosis-I","volume":"7","author":"Yano","year":"2013","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ymgmr.2023.101036_bb0090","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jvs.2011.12.038","article-title":"TGF-beta increases vascular smooth muscle cell proliferation through the Smad3 and ERK MAPK pathways","volume":"56","author":"Suwanabol","year":"2012","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.jhh.1002101","article-title":"Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade","volume":"21","author":"Dandona","year":"2007","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0100","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1161\/01.CIR.0000150540.54220.C4","article-title":"Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor","volume":"110","author":"Daugherty","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ymgmr.2023.101036_bb0105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.biopha.2010.09.014","article-title":"The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice","volume":"64","author":"Fukuda","year":"2010","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: new roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.peptides.2013.05.012","article-title":"Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis","volume":"46","author":"Silveira","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.ymgmr.2023.101036_bb0120","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/ana.24147","article-title":"Losartan prevents acquired epilepsy via TGF-beta signaling suppression","volume":"75","author":"Bar-Klein","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0125","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/jcmm.12128","article-title":"Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis","volume":"17","author":"Wang","year":"2013","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0130","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/npp.2010.225","article-title":"Angiotensin II AT1 receptor blockade ameliorates brain inflammation","volume":"36","author":"Benicky","year":"2011","journal-title":"Neuropsychopharm"},{"key":"10.1016\/j.ymgmr.2023.101036_bb0135","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.2174\/1381612811319170003","article-title":"Angiotensin II type 1 and type 2 receptor-induced cell signaling","volume":"19","author":"Akazawa","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.regpep.2007.12.005","article-title":"Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappa B-dependent pathway in vascular smooth muscle cells","volume":"147","author":"Guo","year":"2008","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.coph.2013.01.002","article-title":"Conundrum of angiotensin II and TGF-beta interactions in aortic aneurysms","volume":"13","author":"Chen","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0150","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.1192149","article-title":"Noncanonical TGF-beta signaling contributes to aortic aneurysm progression in Marfan syndrome mice","volume":"332","author":"Holm","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ymgmr.2023.101036_bb0155","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.2174\/1381612811319170005","article-title":"Class- and molecule-specific differential effects of angiotensin II type 1 receptor blockers","volume":"19","author":"Imaizumi","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10545-016-9988-z","article-title":"Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology","volume":"40","author":"Osborn","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10545-017-0014-x","article-title":"Losartan improves aortic dilatation and cardiovascular disease in mucopolysaccharidosis I","volume":"40","author":"Gonzalez","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0170","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jimd.12327","article-title":"Cardiac pathology in mucopolysaccharidosis I mice: losartan modifies ERK1\/2 activation during cardiac remodeling","volume":"44","author":"Gonzalez","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0175","series-title":"Madame Curie Bioscience Database [Internet]","article-title":"Cytokines, Chemokines and Their Receptors","author":"Cameron","year":"2000"},{"key":"10.1016\/j.ymgmr.2023.101036_bb0180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymgme.2014.10.012","article-title":"Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy","volume":"114","author":"Langereis","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203216","article-title":"Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy","volume":"13","author":"Pal","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgmr.2023.101036_bb0190","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1046\/j.1523-1755.62.s82.4.x","article-title":"Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney","author":"Ruiz-Ortega","year":"2002","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0195","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1161\/01.RES.86.12.1187","article-title":"Cytokine actions of angiotensin II","volume":"86","author":"Sadoshima","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0200","first-page":"524","article-title":"Gender-related dimorphism in aortic insufficiency in murine mucopolysaccharidosis type I","volume":"18","author":"Tolar","year":"2009","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0205","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0210","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1093\/ndt\/gfr767","article-title":"Losartan prevents the development of the pro-inflammatory monocytes CD14+CD16+ in haemodialysis patients","volume":"27","author":"Merino","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0215","first-page":"11","article-title":"Angiotensin II type 1 receptor antagonist losartan inhibits TNF-\u03b1-induced inflammation and degeneration processes in human nucleus pulposus cells","author":"Saravi","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0220","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/hr.2010.79","article-title":"Losartan inhibits LPS-induced inflammatory signaling through a PPAR\u03b3-dependent mechanism in human THP-1 macrophages","volume":"33","author":"An","year":"2010","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0225","first-page":"CD009354","article-title":"Enzyme replacement therapy with laronidase (Aldurazyme\u00ae) for treating mucopolysaccharidosis type I","author":"Jameson","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0230","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.omtm.2017.09.008","article-title":"A humoral immune response alters the distribution of enzyme replacement therapy in murine Mucopolysaccharidosis type I","volume":"8","author":"Le","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymgmr.2023.101036_bb0235","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.omtm.2020.12.014","article-title":"Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-batten disease mice","volume":"20","author":"White","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426923000824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426923000824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:54:56Z","timestamp":1762001696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426923000824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":47,"alternative-id":["S2214426923000824"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2023.101036","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type I","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2023.101036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101036"}}